On ECHEMI
Home > Drugs > Yunnan Lanlukang Pharmaceutical Co., Ltd.
Yunnan Lanlukang Pharmaceutical Co., Ltd.
  • Founded in:

    1999-07-26
  • Country:

    China China
  • Address:

    No. 176, Keyi Road, High-tech Industrial Development Zone, Kunming, Yunnan Province
  • Tax NO.:

    915301007134388620
  • Registered Funds:

    68 million yuan
  • Website:

  • Email:

Related Drugs
Qishenlian Eczema Cream
Main ingredients: Coptis chinensis, Sophora flavescens, Atractylodes lancea, Paris polyphylla, Panax notoginseng, Dictamni cortex, Calamine, Zanthoxylum bungeanum, Borneol, Licorice.
Name Description Content CAS NO. Registered Holders
COPTIDISRHIZOMA

Clears away heat and dries dampness

More

Clears away heat and dries dampness

0
SOPHORAE FLAVESCENTIS RADIX

Clears away heat and dries dampness

More

Clears away heat and dries dampness

0
ATRACTYLODIS RHIZOMA

Clears away heat and dries dampness

More

Clears away heat and dries dampness

0
Extract of Paris polyphylla

Clears away heat and dries dampness

More

Clears away heat and dries dampness

0
NOTOGINSENG RADIX ET RHIZOMA

Activate blood circulation and reduce swelling

More

Activate blood circulation and reduce swelling

0
white fresh skin

Dispel wind and relieve itching

More

Dispel wind and relieve itching

0
CALAMINE

Dispel wind and relieve itching

More

Dispel wind and relieve itching

8011-96-9 4
Prickly ash

Dispel wind and relieve itching

More

Dispel wind and relieve itching

0
Borneol

Dispel wind and relieve itching

More

Dispel wind and relieve itching

507-70-0 1
DGL

Clears away heat and dries dampness

More

Clears away heat and dries dampness

0
Qishenlian Eczema Cream
Main ingredients: Coptis chinensis, Sophora flavescens, Atractylodes lancea, Paris polyphylla, Panax notoginseng, Dictamni cortex, Calamine, Zanthoxylum bungeanum, Borneol, Licorice.
Name Description Content CAS NO. Registered Holders
COPTIDISRHIZOMA

Clears away heat and dries dampness

More

Clears away heat and dries dampness

0
SOPHORAE FLAVESCENTIS RADIX

Clears away heat and dries dampness

More

Clears away heat and dries dampness

0
ATRACTYLODIS RHIZOMA

Clears away heat and dries dampness

More

Clears away heat and dries dampness

0
Extract of Paris polyphylla

Clears away heat and dries dampness

More

Clears away heat and dries dampness

0
NOTOGINSENG RADIX ET RHIZOMA

Activate blood circulation and reduce swelling

More

Activate blood circulation and reduce swelling

0
white fresh skin

Dispel wind and relieve itching

More

Dispel wind and relieve itching

0
CALAMINE

Dispel wind and relieve itching

More

Dispel wind and relieve itching

8011-96-9 4
Prickly ash

Dispel wind and relieve itching

More

Dispel wind and relieve itching

0
Borneol

Dispel wind and relieve itching

More

Dispel wind and relieve itching

507-70-0 1
DGL

Clears away heat and dries dampness

More

Clears away heat and dries dampness

0
Lovastatin Capsules
Main ingredients: The main ingredient of this product is lovastatin. Its chemical name is (S)-2-methylbutyric acid-(1S,3S,7S,8S,8aR)1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-{2-[(2R,4R)-4-hydroxy-6-oxo-2-tetrahydropyranyl]-ethyl}-1-naphthyl ester. Molecular formula: C24H36O5, molecular weight: 404.55.
Name Description Content CAS NO. Registered Holders
Lovastatin

In vivo, it competitively inhibits the rate-limiting enzyme hydroxymethylglutaryl coenzyme A reductase in the cholesterol synthesis process, reducing the synthesis of cholesterol and increasing the synthesis of low-density lipoprotein receptors. Its main site of action is in the liver, resulting in lower blood cholesterol and low-density lipoprotein cholesterol levels, thereby playing a role in the prevention and treatment of atherosclerosis and coronary heart disease. This product also reduces serum triglyceride levels and increases blood high-density lipoprotein levels.

More

In vivo, it competitively inhibits the rate-limiting enzyme hydroxymethylglutaryl coenzyme A reductase in the cholesterol synthesis process, reducing the synthesis of cholesterol and increasing the synthesis of low-density lipoprotein receptors. Its main site of action is in the liver, resulting in lower blood cholesterol and low-density lipoprotein cholesterol levels, thereby playing a role in the prevention and treatment of atherosclerosis and coronary heart disease. This product also reduces serum triglyceride levels and increases blood high-density lipoprotein levels.

75330-75-5 38
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.